Second Question of the Day October 1, 2013 Does this type of illegal activity still occur in the veterinary or animal medication world? Does the EPA or State Agriculture Agencies Still Get Involved?

News Releases By Date

EATON VETERINARY LAB (also known as Roadrunner) ORDERED TO STOP SELLING ILLEGAL PET PRODUCTS

Release Date: 2/9/2000

Contact Information: Paula Bruin, U.S. EPA, (415) 744-1587

SAN FRANCISCO -- The U.S. Environmental Protection Agency today issued Stop Sale Orders against Eaton Veterinary Laboratories of Phoenix, Ariz., for selling unregistered flea products. The company sold and distributed unregistered versions of the popular flea-control products "Advantage for Dogs," "Advantage for Cats," "Frontline Top Spot Cat," and "Frontline Top Spot Dog."

Both Advantage and Frontline products are missing required labeling information about how to use the products safely. The unregistered Frontline pet products must include the warning that children are prohibited from applying the product. Also missing from the label is the restriction that the product must not be reapplied for 30 days. The unregistered Advantage pet products are missing language on the label about First Aid instructions and storage and disposal requirements.

The EPA will not register a pesticide until it has been tested to show that it will not pose an unreasonable risk when used according to the directions. The Agency also makes sure that pesticide labels provide consumers with the information they need to use the products safely. Pesticide products that have undergone this review process are recognizable by the EPA registration number printed on the label.

There has been a recent increase in the number of companies bringing unregistered pet products into the United States. Last year EPA assessed a fine against a San Diego pet store for selling unregistered Advantage for Dogs and Advantage for Cats. Also, a Stop Sale Order was issued to a distributor for importing unregistered Advantage products from Mexico with Spanish labeling.

The EPA's Action today was based on inspections conducted by Arizona Department of Agriculture and Virginia Department of Agriculture and Consumer Services.

Question of the Day October 1, 2013, Is anyone including Congress, the FDA, and State Boards of Pharmacy, paying attention to what is going on in the compounding pain medication world? The discussion on CafePharma board is very telling.

ny pain reps looking to make 10K to 40K per month on the side?

---

With all the connections you Pfizer reps have and are paid so little in comparison to the huge revenue I was just wondering if any of you would be interested in earning an extra 10K to 40K per month? Our company not only has a compounding pharmacy that you can promote but also 2 additional services that our reps promote with one being the industry leader in Genetic DNA testing via oral swab. The need for personalized medicine is growing rapidly and physicians are looking for genetic help to pick which medication is right or wrong for a patient and what dose they should start them on. The third service is a drug testing confirmation lab.
The real money maker for most reps in the compounding pharmacy which is why the industry is exploding right now. Everyone has seen Voltaren Gel promoted in your offices and it only has one active ingredient which is Diclofenac with a 1% concentration. Our pharmacy combines an NSIAD like Diclofenac but with at least a 3% concentration along with many other active ingredients to offer a product that typically offers much better pain reduction and is applicable to many more conditions and patients. Doesn't it make perfect sense that if you take that NSAID along with a muscle relaxer, a neuropathic pain med like Gabapentin, and throw in a topical anesthetic that you could treat a wide range of pain patients? Considering that we have meds to treat wounds and scar and that the aver reimbursement is around $1,800 per script and a rep earning 20% to 24% commission you can see why we had a rep work 4 hours in their first week working just Thursday & Friday and earned $2,500 off of 3 physicians. When they went back on Monday the physician had already written 7 new scripts so they could easily end up earning about 11K this week. If you consider that we pay a commission on every scripts whether it is a new RX or a refill you can see why reps are earning 10K to 40K per month. If you can find 20 physicians to write just 1 script per week you should earn about 28K per month. Keep in mind that those do not have to be new scripts, that could be 10 physicians who wrote 1 script per week last month and those patients got refills and you are right back at 20 scripts per week. When you factor how many scripts you might get in the third month you see why this is so attractive. You are a 1099 rep which means you are your own boss with no reports to turn in, no one micromanaging you, you can be at the beach every day and never make another sales call but if your physicians keep sending in scripts we keep paying you month after month year after year. Let's just say that there are a lot of reps both pharmaceutical and medical device that are finally jumping up in the morning excited about going to work as they finally are getting to work for themselves. Big pharma always talks about taking ownership and running the territory like you own it but they never pay you like you own it. You never have any quotas or sales number to hit and it’s the best residual income you will ever earn. The biggest hurdle reps have it getting past their concern that this is real and not some scam but it doesn't take much research to find out this industry is exploding. If you are interested you can go to our website at www dot SupremeMedSolutions dot com or you can email me at tisley at chartertn dot net. We offer the highest commission in the industry and multiple products you can sell and earn that high residual income on. What have you got to lose in finding out a little more info?

Quoted from CafePharma Board found here